A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides

Published:2017-03 Issue:2 Volume:7 Page:223-229
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Liu Hongtao,Pang Guoxun,Ren Jinfeng,Zhao Yue,Wang Juxian

Funder

National Natural Science Foundation of China

Hebei Provincial Key Research Project of Medical Science

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference22 articles.

1. Review of the major intervention trials of lowering coronary artery disease risk through cholesterol reduction;Stark;Am J Cardiol,1996

2. Fifty years of advances in bile acid synthesis and metabolism;Russell;J Lipid Res,2009

3. The solute carrier family 10 (SLC10): beyond bile acid transport;da Silva;Mol Asp Med,2013

4. Absence of dysfunctional ileal sodium? Bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption;Montagnani;Scand J Gastroenterol,2001

5. Role of the intestinal bile acid transporters in bile acid and drug disposition;Dawson,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile salt signaling and bile salt-based therapies in cardiometabolic disease;Clinical Science;2024-01

2. Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non‐alcoholic fatty liver disease;Acta Physiologica;2023-12

3. BILE ACID TRANSPORTERS;Drug Transporters;2022-04-05

4. Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways;Bioorganic & Medicinal Chemistry;2021-11

5. Inhibitors of the Apical Sodium-Dependent Bile Acid Transporter (ASBT) as Promising Drugs;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3